Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy

被引:6
|
作者
Pili-Floury, Sebastien [1 ,2 ,3 ]
Royer, Bernard [4 ,5 ]
Bartholin, Frederique [1 ]
Crumiere, Nathalie [1 ]
Combe, Marielle [1 ]
Chalopin, Jean-Marc [2 ,5 ,6 ]
Pivot, Xavier [2 ,5 ,7 ]
Heyd, Bruno [2 ,5 ,8 ]
Chauffert, Bruno [9 ]
Samain, Emmanuel [1 ,2 ,3 ]
机构
[1] CHU Besancon, Dept Anesthesiol & Intens Care Med, F-25000 Besancon, France
[2] Univ Franche Comte, F-25000 Besancon, France
[3] INSERM IFR 133, EA 3920, F-25000 Besancon, France
[4] CHU Besancon, Dept Pharmacol, F-25000 Besancon, France
[5] INSERM UMR 645, F-25000 Besancon, France
[6] CHU Besancon, Dept Nephrol, F-25000 Besancon, France
[7] CHU Besancon, Dept Oncol, F-25000 Besancon, France
[8] CHU Besancon, Dept Gen Surg, F-25000 Besancon, France
[9] Georges Francois Leclerc Ctr, Dept Oncol, F-21000 Dijon, France
关键词
Ovarian cancer; Intraperitoneal chemotherapy; Cisplatin; Epinephrine; Renal function; CYTOREDUCTIVE SURGERY; INTRAPERITONEAL CHEMOTHERAPY; OVARIAN-CANCER; NEPHROTOXICITY; FAILURE; FEASIBILITY; CARBOPLATIN; MORTALITY; CARCINOMA;
D O I
10.1016/j.ejogrb.2011.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Intra-operative cisplatin-based intra-peritoneal chemotherapy (IPC) may alter renal function in patients with advanced ovarian cancer. The aim of this study was to describe postoperative alteration of renal function after cisplatin-based IPC and to identify risk factors for moderate to severe acute renal failure. Study design: This prospective observational study was carried out on 77 consecutive patients who underwent cisplatin-based IPC procedures, with (n = 23) or without (n = 54) intra-peritoneal epinephrine, for advanced ovarian cancer. Postoperative renal function was assessed using serial serum creatinine measurements and was based on serum creatinine changes from pre-operative values, according to the risk, injury, failure, loss, end-stage kidney disease (RIFLE) classification. Patients were divided into two groups according to postoperative renal function: patients with renal injury or failure (IF group) or patients with no renal alteration or renal risk (NR group). Clinical variables were compared between the IF and NR groups using univariate and multivariate analysis. Results: Postoperative acute change in renal function was observed in 34 (44.2%) patients (unimodal distribution), among whom 23 patients (29.8%) constituted the IF group. In univariate analysis, the absence of epinephrine in the IPC bath, a higher duration of severe hypotension, a lower postoperative blood protein level, and a lower volume of intra-operative diuresis were significantly associated with the occurrence of renal injury or failure. In multivariate analysis, the absence of epinephrine was the only factor associated with the occurrence of moderate to severe acute renal failure (odds ratio [95% confidence interval] = 4.49 [1.36-14.80]). Conclusions: Transient acute renal dysfunction after cisplatin-based IPC associated with cytoreductive surgery is frequent and intra-peritoneal epinephrine plays a protective role. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [1] Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
    Guardiola, Emmanuel
    Delroeux, Delphine
    Heyd, Bruno
    Combe, Marielle
    Lorgis, Veronique
    Demarchi, Martin
    Stein, Ulrich
    Royer, Bernard
    Chauffert, Bruno
    Pivot, Xavier
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7
  • [2] Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
    Emmanuel Guardiola
    Delphine Delroeux
    Bruno Heyd
    Marielle Combe
    Veronique Lorgis
    Martin Demarchi
    Ulrich Stein
    Bernard Royer
    Bruno Chauffert
    Xavier Pivot
    World Journal of Surgical Oncology, 7
  • [3] Hyperthermic intra-peritoneal chemotherapy and anticancer immune response
    Zunino, Barbara
    Ricci, Jean-Ehrland
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [4] Recent Advances in Intra-peritoneal Chemotherapy for Gastric Cancer
    Chia, Daryl K. A.
    So, Jimmy B. Y.
    JOURNAL OF GASTRIC CANCER, 2020, 20 (02) : 115 - 126
  • [5] CLINICAL DELIVERY SYSTEM FOR INTRA-PERITONEAL HYPERTHERMIC CHEMOTHERAPY
    SPRATT, JS
    ADCOCK, RA
    MUSKOVIN, M
    SHERRILL, W
    MCKEOWN, J
    CANCER RESEARCH, 1980, 40 (02) : 256 - 260
  • [6] Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis
    Angeles, Martina Aida
    Quenet, Francois
    Vieille, Pierre
    Gladieff, Laurence
    Ruiz, Jean
    Picard, Muriel
    Migliorelli, Federico
    Chaltiel, Leonor
    Martinez-Gomez, Carlos
    Martinez, Alejandra
    Ferron, Gwenael
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 382 - 391
  • [7] Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
    Verwaal, VJ
    Van Tinteren, H
    Ruth, SV
    Zoetmulder, FAN
    JOURNAL OF SURGICAL ONCOLOGY, 2004, 85 (02) : 61 - 67
  • [8] Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy
    Arslan, Naciye Cigdem
    Sokmen, Selman
    Avkan-Oguz, Vildan
    Obuz, Funda
    Canda, Aras Emre
    Terzi, Cem
    Fuzun, Mehmet
    SURGICAL INFECTIONS, 2017, 18 (02) : 157 - 163
  • [9] SOME EFFECTS OF INTRA-PERITONEAL GLUCOSE UPON RENAL FUNCTION IN DOGS
    HERRIN, RC
    AMERICAN JOURNAL OF PHYSIOLOGY, 1954, 179 (03): : 644 - 644
  • [10] Effect of Liposomal Doxorubicin in Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC)
    Mikolajczyk, Agata
    Khosrawipour, Veria
    Schubert, Justyna
    Grzesiak, Jakub
    Chaudhry, Haris
    Pigazzi, Alessio
    Khosrawipour, Tanja
    JOURNAL OF CANCER, 2018, 9 (23): : 4301 - 4305